HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account
Why Understanding Myeloma Genomics Should Matter To African Americans with Dr. Gareth Morgan, Nov 11 @ 1 PM Eastern
Posted: Nov 04, 2021
Why Understanding Myeloma Genomics Should Matter To African Americans with Dr. Gareth Morgan, Nov 11 @ 1 PM Eastern  image

Join the African American Myeloma Community Chapter on November 11th @ 1 PM Eastern 

The African American Myeloma Community Chapter is pleased to welcome internationally recognized clinician-scientist, Dr. Gareth Morgan, to our Chapter. Join us to virtually meet and ask your questions to one of the great myeloma doctors of our day. Dr. Morgan's expertise is in the field of molecular genetics and the treatment of multiple myeloma. During this meeting, he will discuss the role that our genetics play in myeloma treatment and targeted therapy. How does it differ in the African American myeloma population and what can we do with this knowledge once we have it?


Register Today!


Why meet Dr. Morgan? 

Dr. Morgan truly finds joy in meeting and interacting with his patients. 

He says,

"Medicine was a natural career choice for me because of my interest in the biological sciences, in people, and in their health. I chose hematology—the diagnosis and treatment of blood diseases—as a specialty because I loved the idea of using laboratory investigation to understand disease pathology and use that information to personalize treatment."


As director of multiple myeloma research at NYU Langone’s Perlmutter Cancer Center, Dr. Morgan works with a team of premier doctors who provide outstanding care for patients with multiple myeloma. He feels it a privilege to be able to offer his patients the best advice and care as part of a program that is focused on finding a cure for myeloma and keeping people disease-free for the longest period of time possible after their treatment.

He has pioneered studies on the genetics and treatment of multiple myeloma and has published more than 500 peer-reviewed articles in leading journals. He also speaks regularly at major scientific meetings.

Dr. Morgan is doing influential work on the characterization of the myeloma genome, defining specific subsets of the disease that have prognostic importance, and developing personalized therapeutic strategies targeted to each subtype. He is also engaged in advanced research in molecular diagnostics, drug development, and clinical trials. His research aims to cure myeloma and to reduce side effects by targeting treatment to the biology underlying each patient’s cancer.

We look forward to meeting with Dr. Morgan and each of you as he shares some of his knowledge and expertise with us. Sign up today! 


Register Today!



If you are interested in joining the African American Myeloma Community Chapter that I lead, please click the button below. We meet monthly together in a virtual format. I look forward to meeting you! 


Join Our Chapter


Thank you to NYU Langone for the excellent bio of Dr. Gareth Morgan. 


The author Valarie Traynham

about the author
Valarie Traynham

Valarie Traynham has been a myeloma survivor since 2015. Wanting to be a source of support, provide patient education and encouragement to help others along their myeloma journey, she is a volunteer myeloma coach, myeloma support group leader and patient advocate. She enjoys being outdoors, reading, and trying new recipes.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology

Follow Us

facebook instagram twitter youtube